BHAGCHEMBhagiradha Chemicals & Industries Limited Forensic Risk Analysis

Pesticides & Agrochemicals
Risk ClassStable
Market Cap₹2,600 Cr
Primary DriverBalance Sheet Stress
Flagium AI Risk Score
Stable structural profile. Financial profile appears resilient.
7 / 100
-5 QoQ
Improving
Sentinel Insight

Financial profile remains stable for now. Pressure is receding in balance sheet stress. This indicates that forensic pressure is currently receding. Risk levels are improving.

22.2th %ile (Sector)Accel: +0 Qtrs
Updated2026-06-02
Market View
240.11.4%
PeriodQ4 FY26

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

Balance Sheet Stress
+6.4 pts
Stability Adjustment
+1.0 pts
Final Composite Risk7 / 100

Investment Risk Thesis

Historical Trend

Current risk score has declined from 167 over 13 quarters.

Expected Direction
🟢 Improving
Primary Deterioration Drivers
  • Margin Compression
  • Inventory Stress
  • Industrial Margin Stress
What to Watch Next Quarter
  • Operating profit margins
  • Working capital efficiency
  • Operating cash flow

Active Risk Objects (11)

CriticalHigh
Margin Compression
📊 Earnings QualityAnnualActive for 1 Years
More Detail
Impact Weight15/15
MomentumAccelerating
Last SignalQ1 FY2026
Operating margin declined by 6.5 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Capex Efficiency Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ2 FY2025
Aggressive Capex (76.2%) amidst slow revenue growth (-12.4%).

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Industrial Margin Stress
📊 Earnings QualityAnnualActive for 4 Years
More Detail
Impact Weight12/15
MomentumPersistent
Last SignalQ3 FY2026
BHAGCHEM: Raw material costs consumed an additional 19.5% of revenue YoY.

"Margins are in freefall. Operating costs are growing significantly faster than revenue."

Working Capital Expansion
💧 Liquidity & CoverageAnnualActive for 2 Years
More Detail
Impact Weight10/15
MomentumDecaying
Last SignalQ4 FY2025
Working capital expansion detected: Receivable days increased by 47.6%.

"Working capital pressure is receding. Cash previously locked in operations is being released."

Negative FCF Streak
⚖️ Governance SignalsAnnualActive for 3 Years
More Detail
Impact Weight6/15
MomentumPersistent
Last SignalFY2026
BHAGCHEM: Negative Free Cash Flow for last 3 consecutive years.

"High capital expenditure and low OCF are draining cash. Debt levels may rise sharply."

Cash Conversion Deficit
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight6/15
MomentumPersistent
Last SignalFY2026
BHAGCHEM: OCF below Net Profit in 2/3 recent years.

"Cash conversion is dangerously low. Operational cash flow is significantly trailing reported PAT."

Profit Collapse
📊 Earnings QualityQuarterlyActive for 4 Qtrs
More Detail
Impact Weight8/15
MomentumDecaying
Last SignalQ4 FY2025
BHAGCHEM: Net Profit collapsed by 112.3% from FY2024 Q4 to FY2025 Q4.

"Earnings quality is stabilizing. The reliance on non-operational items is receding."

Inventory Stress
📊 Earnings QualityAnnualActive for 2 Years
More Detail
Impact Weight15/15
MomentumDecaying
Last SignalQ2 FY2025
Inventory growth (70.0%) significantly outpaced revenue growth (-12.4%).

"Inventory overhang is clearing. Stock levels are normalizing as sales momentum returns."

Low Interest Coverage
💧 Liquidity & CoverageQuarterlyActive for 3 Qtrs
More Detail
Impact Weight8/15
MomentumPersistent
Last SignalQ4 FY2026
BHAGCHEM: Low Interest Coverage Ratio of 1.68x in FY2026 Q4 (Threshold: 2.5x).

"Earnings buffer for interest payments is narrowing. Monitor for margin pressure."

Operating Leverage Stress
📊 Earnings QualityAnnualActive for 3 Years
More Detail
Impact Weight10/15
MomentumPersistent
Last SignalQ2 FY2026
Expenses are consistently growing faster than revenues, creating operational pressure.

"Debt levels are creeping up. Monitor for signs of excessive borrowing for non-core activities."

Revenue-Debt Divergence
🏛️ Solvency & LeverageAnnualActive for 1 Years
More Detail
Impact Weight6/15
MomentumDecaying
Last SignalFY2024
BHAGCHEM: Revenue fell 18.5% while Debt rose 22.9% in 2024 vs 2023.

"Debt servicing metrics have improved recently. The company is actively deleveraging."

Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Resilience Matrix
Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
MetricValuevs SectorSignal
Volatility (σ)7.757.62⚠️ HIGH
Sensitivity (ε_s)11.00✅ RESILIENT
Escalation Prob.5%5%✅ NEUTRAL
Safety Buffer+59.0+46.5✅ RESILIENT
Forensic Benchmark Context: Pesticides & Agrochemicals (n=18 peers)

Correlation Analysis
Visualizing the relationship between stock price movement and structural risk objects.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
240.1(-1.4%)
1M Divergence-11.63%
1 Week-2.52%
1 Month-9.37%
6 Months+2.21%
1 Year-20.28%
2 Year+25.48%
3 Year+49.2%
Sector Average (1M)+2.27%
Sentinel Forensic Assessment
ALGORITHMIC RISK PROFILE • NON-ADVISORY

The structural architecture is currently robust. Capital resilience buffers in balance sheet stress remain well-maintained against forensic benchmarks. Systematic scans of core structural metrics confirm the absence of material structural stress. Initial structural recovery is visible; monitor for a sustained return to resilience.

BHAGCHEM • MARKET STRUCTURE

Stage 1 — Accumulation

The company is in a foundational phase. Risk metrics are stabilizing as the company builds a base for potential future fundamental improvement.

Stage Transition Prob.8%
Trend QualityStabilizing
Phase Progression
Phase Progression Score47.5%
Readiness LabelModerate (Transition Potential Building)
Probability of Advancing8%
CoinTree Momentum
Composite Z-Score+0.0919σ
Improving momentum strength
Universe Rank
A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
#829 of 2716
Top 30.52% in momentum strength
Timeframe Sparklines
1W-2.5%
1M-9.4%
6M+2.2%
Weinstein Indicators
150 DMA227.99
200 DMA237.35
150 DMA Slope-0.1875%Declining
Relative Strength+7.56%Leading
Relative Turnover (RTR)1.0896
ParticipationNeutral

PEER COMPARISON

Ranked comparison against sector peers

This company appears relatively stable compared to the Sector Mean (19.5).

* Peer comparison is based on risk signals, not valuation or returns.

Risk Profiles

Solvency
10100th %ile
VS Sector Median (8.5)
Governance
10100th %ile
VS Sector Median (8.5)
Earnings Quality
10100th %ile
VS Sector Median (8.5)
Balance Sheet Stress
6.868th %ile
VS Sector Median (8.5)
Competitive Position
10100th %ile
VS Sector Median (8.5)
Growth Sustainability
10100th %ile
VS Sector Median (8.5)

Deterioration Timeline

2026

Industrial Margin Stress

2026

Operating Leverage Stress

2026

Industrial Margin Stress

2026

Margin Compression

2026

Operating Leverage Stress

2026

Negative FCF Streak

2026

Cash Conversion Deficit

2025

Operating Leverage Stress

2025

Industrial Margin Stress

2025

Working Capital Expansion

2025

Inventory Stress

2025

Capex Efficiency Stress

2025

Cash Conversion Deficit

2025

Negative FCF Streak

2024

Inventory Stress

2024

Industrial Margin Stress

2024

Working Capital Expansion

2024

Capex Efficiency Stress

2024

Cash Conversion Deficit

2024

Negative FCF Streak

2024

Revenue-Debt Divergence

Key Financials (INR Cr)

PeriodRevenueNet ProfitOCFDebt
FY20265381812231
FY202545014-5384
FY2024410183461
FY2023503451450